Clinical trial
The Effect of a Tablet-based Aphasia Therapy in the Chronic Phase After Stroke
NCT03622411 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of a Tablet-based Aphasia Therapy in the Chronic Phase After Stroke
- Lead sponsor
- University Hospital, Ghent
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 7, 2018
- Completion date
- February 23, 2021
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.